Metraipolis › archive › dc_9f7ead388ffc
The impact of antinuclear antibodies and complement levels in the prognosis of pregnant women within the antiphospholipid syndrome spectrum — Europe PMC PMID:42327739
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42327739
- DOI
- 10.3389/fimmu.2026.1818605
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-31T17:20:12.834Z
- SHA-256 of the archived text
455f8534d594184e7c09e400f8b966bd6c7c475c70102f423c137cbbea70bd23- Stable URL of this page
https://metraipolis.com/documento/dc_9f7ead388ffc
How to cite
The impact of antinuclear antibodies and complement levels in the prognosis of pregnant women within the antiphospholipid syndrome spectrum — Europe PMC PMID:42327739 — Europe PMC (en), https://europepmc.org/article/MED/42327739 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_9f7ead388ffc (Metraipolis archive dc_9f7ead388ffc, sha256 455f8534d594184e7c09e400f8b966bd6c7c475c70102f423c137cbbea70bd23)
BibTeX
@misc{dc9f7ead388ffc,
title = {The impact of antinuclear antibodies and complement levels in the prognosis of pregnant women within the antiphospholipid syndrome spectrum — Europe PMC PMID:42327739},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42327739},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_9f7ead388ffc; sha256 455f8534d594184e7c09e400f8b966bd6c7c475c70102f423c137cbbea70bd23},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42327739. Agents can read the archived copy with the MCP tool read_document.